China SXT Pharmaceuticals (SXTC) Total Non-Current Liabilities (2019 - 2026)
China SXT Pharmaceuticals' Total Non-Current Liabilities was $697,832 in fiscal Q4 2026 (quarter ended Mar 31, 2026), up 229.7% from $211,683 a year earlier.
Powered by 
Analysis
China SXT Pharmaceuticals (SXTC) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
From fiscal Q4 2019 onward, China SXT Pharmaceuticals has reported Total Non-Current Liabilities for 15 quarters.
- Total Non-Current Liabilities shows a five-year compound annual growth rate of 156.4% (FY2021 to FY2026).
- In earlier fiscal years, Total Non-Current Liabilities was $211,683 in FY2025 (-28.2%), $294,667 in FY2024 (-19.5%), $365,823 in FY2023 (-97.9%) and $17.34 million in FY2022.
- The fiscal Q4 2026 figure marks the highest quarterly Total Non-Current Liabilities since fiscal Q2 2023.
- Compared with a year earlier, Total Non-Current Liabilities was higher in 1 of the last four quarters, with growth averaging 37.6%.
- The best year-over-year quarter for Total Non-Current Liabilities over five years was fiscal Q4 2026 (growth of 229.7%); the worst was fiscal Q4 2023 (a decline of 97.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 5.92 Bn |
| 10 | China SXT Pharmaceuticals | 33,069.96 | -85.92 Mn | - | 697,832.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 697,832.00 |
| Sep 30, 2025 | 158,263.00 |
| Mar 31, 2025 | 211,683.00 |
| Sep 30, 2024 | 298,011.00 |
| Mar 31, 2024 | 294,667.00 |
| Sep 30, 2023 | 311,512.00 |
| Mar 31, 2023 | 365,823.00 |
| Sep 30, 2022 | 7.52 Mn |
| Mar 31, 2022 | 17.34 Mn |
| Sep 30, 2021 | 8.40 Mn |
| Mar 31, 2021 | 6,292.00 |
| Sep 30, 2020 | 15,213.00 |
| Mar 31, 2020 | 36,511.00 |
| Sep 30, 2019 | 873,282.00 |
| Mar 31, 2019 | 41,706.00 |
API Access
China SXT Pharmaceuticals Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SXTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "SXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();